Lefty inhibits receptor-regulated Smad phosphorylation induced by the activated transforming growth factor-beta

L Ulloa1, S Tabibzadeh

  • 1Department of Pathology, North Shore-Long Island Jewish Health System and Biomedical Research Center, Manhasset, New York 11030, USA.

Insights

Lefty, a novel TGF-beta superfamily member, inhibits transforming growth factor-beta (TGF-beta) and bone morphogenetic protein (BMP) signaling. It blocks R-Smad phosphorylation, preventing downstream gene activation.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-beta) is a key cytokine regulating cell growth and differentiation.
  • TGF-beta signaling involves receptor activation, Smad protein phosphorylation, and nuclear translocation for gene regulation.
  • Understanding negative regulators of TGF-beta signaling is crucial for deciphering cellular processes.

Purpose of the Study:

  • To investigate the inhibitory role of lefty, a novel TGF-beta superfamily member, on TGF-beta and BMP signaling pathways.
  • To elucidate the mechanism by which lefty modulates Smad protein activity and downstream gene expression.
  • To determine if lefty's action is dependent on protein synthesis.

Main Methods:

  • Investigated lefty's effect on Smad2 phosphorylation after TGF-beta receptor activation.
  • Assessed lefty's impact on R-Smad/Smad4 heterodimerization and nuclear translocation.
  • Analyzed lefty's repression of TGF-beta- and BMP-induced reporter gene expression.
  • Examined lefty's effect on Smad5 phosphorylation in BMP signaling.
  • Evaluated the necessity of protein synthesis for lefty's inhibitory function.

Main Results:

  • Lefty inhibits TGF-beta signaling by preventing Smad2 phosphorylation downstream of TGF-beta receptor activation.
  • Lefty interferes with R-Smad heterodimerization with Smad4 and subsequent nuclear translocation.
  • Lefty represses TGF-beta-induced transcription from p21, cdc25, connective tissue growth factor, and Smad-binding element reporter genes.
  • Lefty also inhibits BMP-mediated Smad5 phosphorylation and downstream gene transcription.
  • Lefty's inhibitory action does not require de novo protein synthesis.

Conclusions:

  • Lefty acts as a negative modulator of both TGF-beta and BMP signaling pathways.
  • Lefty inhibits these pathways primarily by blocking the phosphorylation of receptor-regulated Smad proteins (R-Smads).
  • Lefty establishes a repressed state for TGF-beta- and BMP-responsive genes, independent of protein synthesis.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...